Indoleamine 2,3-dioxygenase suppresses the cytotoxicity of NK cells in response to ectopic endometrial stromal cells in endometriosis
article
OA: bronze
CC0
⤵ 11 in-corpus citations
AI-generated summary
Endometrial stromal cells induce indoleamine 2,3-dioxygenase expression in NK cells, suppressing their cytotoxicity towards ectopic endometrial stromal cells in endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
It has been reported that the impaired cytotoxicity of natural killer (NK) cells and abnormal cytokines that are changed by the interaction between ectopic endometrial cells and immune cells is indispensable for the initiation and development of endometriosis (EMS). However, the mechanism of NK cells dysfunction in EMS remains largely unclear. Here, we found that NK cells in peritoneal fluid from women with EMS highly expressed indoleamine 2,3-dioxygenase (IDO). Furthermore, IDO+NK cells possessed lower NKp46 and NKG2D but higher IL-10 than that of IDO-NK. Co-culture with endometrial stromal cells (nESCs) from healthy control or ectopic ESCs (eESCs) from women with EMS led to a significant increase in the IDO level in NK cells from peripheral blood, particularly eESCs, and an anti-TGF-β neutralizing antibody suppressed these effects in vitro. NK cells co-cultured with ESC more preferentially inhibited the viability of nESCs than eESCs did, and pretreating with 1-methyl-tryptophan (1-MT), an IDO inhibitor, reversed the inhibitory effect of NK cells on eESC viability. These data suggest that ESCs induce IDO+NK cells differentiation partly by TGF-β, and that IDO further restricts the cytotoxicity of NK cells in response to eESCs, which provides a potential therapeutic strategy for EMS patients, particularly those with a high number of impaired cytotoxic IDO+NK cells.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis via openalex
- Behaviour of Cytokine Levels in Serum and Peritoneal Fluid of Women with Endometriosis via openalex
- CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions via openalex
- [Changes in NK activities and TGF- beta concentrations in the peritoneal cavity in endometriosis and their interaction related with infertility]. via openalex
- Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis via openalex
- Endometriosis via openalex
- Expression of Natural Cytotoxicity Receptors on Peritoneal Fluid Natural Killer Cell and Cytokine Production by Peritoneal Fluid Natural Killer Cell in Women with Endometriosis via openalex
- Expression of transforming growth factor β1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants via openalex
- Heritable aspects of endometriosis via openalex
- IL15 promotes growth and invasion of endometrial stromal cells and inhibits killing activity of NK cells in endometriosis via openalex
- Immunological aspects of endometriosis: a review. via openalex
- Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway. via openalex
- Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis. via openalex
- In utero exposures and the incidence of endometriosis via openalex
- Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? via openalex
- Potential influence of in utero and early neonatal exposures on the later development of endometriosis via openalex
- The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β via openalex
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis via openalex
- The role of TGF-β in the pathophysiology of peritoneal endometriosis via openalex
- Transforming Growth Factor-β Induced Warburg-Like Metabolic Reprogramming May Underpin the Development of Peritoneal Endometriosis via openalex
- W2146914242 via openalex
- W2159228424 via openalex
- W2167897482 via openalex
- W2754913123 via openalex
- W4288400169 via openalex
- W2118447882 via openalex
- W151780086 via openalex
- W1834981029 via openalex
- W1966538707 via openalex
- W1971130987 via openalex
- W2005465892 via openalex
- W2007316487 via openalex
- W2015260577 via openalex
- W2020036812 via openalex
- W2025156511 via openalex
- W2034000134 via openalex
- W2042200211 via openalex
- W2063945357 via openalex
- W2064981157 via openalex
- W2070311659 via openalex
- W2070371187 via openalex
- W2073300038 via openalex
- W2109281093 via openalex
- W141728048 via openalex
- W2121127545 via openalex
Cited by (14)
- Metabolic remodeling of endometriosis microenvironment: Energy stress and immune evasion 2026
- Metabolic reprogramming in endometriosis: mechanisms and therapeutic prospects 2026
- Immune mechanisms in the pathogenesis of endometriosis: a comprehensive analysis of the role of NK cells, cytokines, and extracellular vesicles/exosomes 2026
- Emerging Mechanisms of NK Cell Dysfunction in Endometriosis: The Role of Autophagy, Metabolism, Cytokines, Exosomes, and Trogocytosis 2025
- eLife Assessment: Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgia, and rescues mice from a negative behavioural phenotype in experimental endometriosis 2024
- Reviewer #2 (Public Review): Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgia, and rescues mice from a negative behavioural phenotype in experimental endometriosis 2024
- Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgesia, and rescues mice from a negative behavioural phenotype in experimental endometriosis 2024
- Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgesia, and rescues mice from a negative behavioural phenotype in experimental endometriosis 2024
- Reviewer #1 (Public Review): Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgia, and rescues mice from a negative behavioural phenotype in experimental endometriosis 2024
- Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgesia, and rescues mice from a negative behavioural phenotype in experimental endometriosis 2024
- Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgia, and rescues mice from a negative behavioural phenotype in experimental endometriosis 2024
- Immunopathogenesis of endometriosis: An overview of the role of innate and adaptive immune cells and their mediators 2022
- The Effect of Mesenchymal Stromal Cells Derived From Endometriotic Lesions on Natural Killer Cell Function 2021
- Anti-inflammatory cytokines in endometriosis 2019
Source provenance
- europepmc
- last seen: 2026-08-23T09:30:01.253652+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:37.156494+00:00
License: CC0
· commercial use OK